荷兰多病共存患者治疗负担量表的翻译与验证:NL-MTBQ研究
本研究将多病共存治疗负担量表(MTBQ)翻译为荷兰语并在959例多病共存患者中验证其心理测量学特性。NL-MTBQ为13条目单因子结构,内部一致性高(α=0.845),构念效度良好,但所有条目存在显著地板效应;中位全局得分为3.85(IQR 0-9.62),代表治疗负担较低。
要点
- NL-MTBQ为13条目单因子量表,内部一致性高(α=0.845),构念效度良好。
- 959例多病共存患者中位全局得分为3.85(IQR 0-9.62),总体治疗负担较低。
- 所有13个条目均存在显著地板效应,可能限制对低负担人群的区分能力。
核心结论
- 荷兰语版13条目MTBQ是单因子结构、有效且简洁的患者报告结局测量工具,可用于评估初级保健多病共存患者的治疗负担。
研究设计与样本
- 横断面研究,将MTBQ翻译为荷兰语(包括正反向翻译、预试验和认知访谈,n=8),并在荷兰面板招募的959例多病共存患者中评估心理测量学特性。
主要发现
- 959例参与者平均年龄69.9岁(范围17-96岁),中位全局NL-MTBQ得分为3.85(四分位距0-9.62),代表治疗负担较低。
- 所有13个条目均发现显著地板效应。
- 因子分析支持单因子结构,NL-MTBQ内部一致性高(α=0.845),构念效度证据良好。
关键数值与推荐
- NL-MTBQ中位全局得分3.85(IQR 0-9.62)对应低治疗负担。
- 内部一致性Cronbach's α=0.845。
- 因子分析支持单因子结构;所有13个条目存在显著地板效应。
临床怎么用
- NL-MTBQ可用于初级保健中识别经历高治疗负担的多病共存患者,有望促进共享决策并提供额外支持。
局限性
- 所有条目存在显著地板效应,可能影响量表在低治疗负担人群中的区分能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multimorbidity is a growing problem. The number and complexity of (non-)pharmaceutical treatments create a great burden for patients. Treatment burden refers to the perception of the weight of these treatments, and is associated with multimorbidity. Measurement of treatment burden is of great value for optimizing treatment and health-related outcomes. OBJECTIVE: We aim to translate and validate the Multimorbidity Treatment Burden Questionnaire (MTBQ) for use in the Dutch population with multimorbidity and explore the level of treatment burden. METHODS: Translating the MTBQ into Dutch included forward-backward translation, piloting, and cognitive interviewing (n = 8). Psychometric properties of the questionnaire were assessed in a cross-sectional study of patients with multimorbidity recruited from a panel in the Netherlands (n = 959). We examined item properties, dimensionality, internal consistency reliability, and construct validity. The level of treatment burden in the population was assessed. RESULTS: The mean age among 959 participants with multimorbidity was 69.9 (17-96) years. Median global NL-MTBQ score was 3.85 (interquartile range 0-9.62), representing low treatment burden. Significant floor effects were found for all 13 items of the instrument. Factor analysis supported a single-factor structure. The NL-MTBQ had high internal consistency (α = 0.845), and provided good evidence on the construct validity of the scale. CONCLUSION: The Dutch version of the 13-item MTBQ is a single-structured, valid, and compact patient-reported outcome measure to assess treatment burden in primary care patients with multimorbidity. It could identify patients experiencing high treatment burden, with great potential to enhance shared decision-making and offer additional support.
引用
- Engels LWS, van Merode T, Heijmans M, et al. Measurement of treatment burden in patients with multimorbidity in the Netherlands: translation and validation of the Multimorbidity Treatment Burden Questionnaire (NL-MTBQ). Fam Pract. 2024. PMID: 37878729. doi:10.1093/fampra/cmad100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。